Motif ID: Hoxb1
Z-value: 1.001
Transcription factors associated with Hoxb1:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Hoxb1 | ENSMUSG00000018973.2 | Hoxb1 |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.8 | GO:0060032 | notochord regression(GO:0060032) |
0.5 | 3.5 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.4 | 5.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.3 | 1.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 2.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 1.7 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 1.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 0.5 | GO:1905154 | negative regulation of tumor necrosis factor secretion(GO:1904468) negative regulation of membrane invagination(GO:1905154) |
0.1 | 0.2 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
0.1 | 2.1 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.7 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.8 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 1.8 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.8 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.7 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 3.1 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.4 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 2.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 1.7 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.2 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.0 | 0.2 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.0 | 0.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 2.3 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.1 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.0 | 0.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.4 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 1.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 1.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 5.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.2 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.0 | 0.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 2.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.7 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.4 | GO:0016235 | aggresome(GO:0016235) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 3.2 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.6 | 3.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.4 | 3.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.7 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.2 | 2.4 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 5.3 | GO:0034930 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.1 | 0.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.4 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.1 | 5.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 1.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 2.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.8 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 2.3 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 1.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 1.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 1.0 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |